Post on : 2018-05-29
Enewstrack.com - The global Liposome Drug Delivery market will reach xxx Million USD in 2017 and CAGR xx% 2011-2017. Report published on 23-May-2018 and available for US$2980.00 at logicresearch.net
Global Liposome Drug Delivery Market Analysis 2012-2017 and Forecast 2018-2023 report covers share, size, strategic industry analysis, emerging industry trends, growth opportunities, demand, supply, and forecasts.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Liposome Drug Delivery by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Liposomal Amphoteracin B
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Johnson & Johnson
Shanghai New Asia
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Fungal Infection Therapy
Cancer & Tumor Therapy
Region Coverage (Regional Output, Demand & Forecast by Countries etc.):
Middle East & Africa
“Global Liposome Drug Delivery Market Analysis Trends, Share and Forecast 2018-2023”